Laura Brege Insider Trading $PCRX Pacira BioSciences, Inc.
Get free email notifications about insider trading for Laura Brege.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Laura Brege. Laura Brege is EVP and Chief Business Officer in ONYX PHARMACEUTICALS INC ($ONXX) and in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in DYNAVAX TECHNOLOGIES CORP ($DVAX) and Director in ANGIOTECH PHARMACEUTICALS INC ($ANPI) and Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and Director in Pacira Pharmaceuticals, Inc. ($PCRX) and Director in ARATANA THERAPEUTICS, INC. ($PETX) and Director in Mirum Pharmaceuticals, Inc. ($MIRM).
Laura Brege in Pacira BioSciences, Inc.
Trading Symbol: PCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Laura Brege: Director
Holdings: 7,921 shares
Current Value: $330,702
Latest Transaction: Jun 11 2020
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Laura Brege in Pacira BioSciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, ANPI, PETX, DVAX, MIRM, ONXX, PCRX, PTLA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Grant | A | 0.00 | 1,260 | 0 | 7,921 | 6.7 K to 7.9 K (+18.92 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Sell | S | 48.70 | 2,100 | 102,270 | 6,661 | 8.8 K to 6.7 K (-23.97 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
Jun 06 2019 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Grant | A | 0.00 | 4,134 | 0 | 8,761 | 4.6 K to 8.8 K (+89.35 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 782 | 0 | 4,627 | 3.8 K to 4.6 K (+20.34 %) |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 1,357 | 0 | 3,845 | 2.5 K to 3.8 K (+54.54 %) |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 1,488 | 0 | 2,488 | 1,000 to 2.5 K (+148.80 %) |
Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Sell | S | 46.95 | 1,000 | 46,950 | 1,000 | 2 K to 1,000 (-50.00 %) |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Page: 1